Skip to content

Vicore Pharma publishes the Annual Report for 2021

Gothenburg, April 7, 2022 – Vicore Pharma Holding AB (publ) (“Vicore”), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2 receptor (ATRAGs), today announced the publication of the Annual Report for the financial year 2021.

The Annual Report for the financial year 2021 is available on the company’s website:

For further information, please contact:
Hans Jeppsson, CFO, tel: +46 70 553 14 65,  

This information is information that Vicore Pharma Holding AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 08:00 CET on 7 April 2022.

Vicore Pharma Holding Annual Report 2021

Source: Vicore Pharma